[go: up one dir, main page]

WO2009053733A3 - Nouvelles formes cristallines - Google Patents

Nouvelles formes cristallines Download PDF

Info

Publication number
WO2009053733A3
WO2009053733A3 PCT/GB2008/050967 GB2008050967W WO2009053733A3 WO 2009053733 A3 WO2009053733 A3 WO 2009053733A3 GB 2008050967 W GB2008050967 W GB 2008050967W WO 2009053733 A3 WO2009053733 A3 WO 2009053733A3
Authority
WO
WIPO (PCT)
Prior art keywords
crystalline forms
novel crystalline
novel
relates
tegaserod
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2008/050967
Other languages
English (en)
Other versions
WO2009053733A2 (fr
Inventor
Abhay Gaitonde
Bindu Manojkumar
Sandeep Sonawane
Dattatrey Kokane
Sinderpal Tank
Vikas Padalkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Mylan Pharmaceuticals Pvt Ltd
Original Assignee
Generics UK Ltd
Mylan Development Centre Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd, Mylan Development Centre Pvt Ltd filed Critical Generics UK Ltd
Publication of WO2009053733A2 publication Critical patent/WO2009053733A2/fr
Publication of WO2009053733A3 publication Critical patent/WO2009053733A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouvelles formes cristallines d'un sel de succinate de tégasérod ainsi que des procédés de préparation de ces nouvelles formes cristallines. L'invention concerne également des compositions pharmaceutiques contenant ces nouveaux polymorphes ainsi que les utilisations desdites compositions dans des méthodes de traitement de patients souffrant de troubles gastro-intestinaux.
PCT/GB2008/050967 2007-10-24 2008-10-18 Nouvelles formes cristallines Ceased WO2009053733A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2105MU2007 2007-10-24
IN2105/MUM/2007 2007-10-24

Publications (2)

Publication Number Publication Date
WO2009053733A2 WO2009053733A2 (fr) 2009-04-30
WO2009053733A3 true WO2009053733A3 (fr) 2009-09-03

Family

ID=40210703

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2008/050967 Ceased WO2009053733A2 (fr) 2007-10-24 2008-10-18 Nouvelles formes cristallines

Country Status (1)

Country Link
WO (1) WO2009053733A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116953A1 (fr) * 2005-05-02 2006-11-09 Zentiva, A.S. Procede de preparation de tegaserod et de sels sélectionnés dérivés de ce composé
EP1939176A1 (fr) * 2006-12-22 2008-07-02 Novartis AG Sels de Tegaserod
WO2008149154A2 (fr) * 2007-06-05 2008-12-11 Generics [Uk] Limited Nouveaux sels et nouvelles formes polymorphiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0297651B1 (fr) 1987-06-29 1993-11-03 Duphar International Research B.V Dérivés d'indole annulaires
HUT64023A (en) 1991-03-22 1993-11-29 Sandoz Ag Process for producing aminoguanidine derivatives and pharmaceutical compositions comprising such compounds
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116953A1 (fr) * 2005-05-02 2006-11-09 Zentiva, A.S. Procede de preparation de tegaserod et de sels sélectionnés dérivés de ce composé
EP1939176A1 (fr) * 2006-12-22 2008-07-02 Novartis AG Sels de Tegaserod
WO2008149154A2 (fr) * 2007-06-05 2008-12-11 Generics [Uk] Limited Nouveaux sels et nouvelles formes polymorphiques

Also Published As

Publication number Publication date
WO2009053733A2 (fr) 2009-04-30

Similar Documents

Publication Publication Date Title
WO2008132139A3 (fr) Nouveaux dérivés hétérocycliques utiles pour le traitement des troubles du système nerveux central
WO2008001195A3 (fr) Nouveaux procédés de synthèse d'inhibiteurs de dpp iv
WO2008152099A3 (fr) Aryl/hétarylamides en tant que modulateurs du récepteur ep2
WO2009064460A3 (fr) Systèmes de délivrance aux voies gastro-intestinales
WO2009104021A3 (fr) Nouveaux polymorphes et procédés de préparation
WO2009111700A3 (fr) Oxadiazoanthracènes pour le traitement du diabète
WO2010011772A3 (fr) Inhibiteurs de la pyrazolopyridine kinase tricyclique
WO2011082266A3 (fr) Composés hétérocycliques substitués
WO2009067686A3 (fr) Hémi-l-malate de sunitinib, polymorphes et leur préparation, polymorphes de malate de sunitinib racémique, compositions contenant une base de sunitinib et de l'acide malique et leur préparation
WO2010055082A3 (fr) Nouvelle forme cristalline de malate de sunitinib
WO2008152093A3 (fr) Diaminopyrimidines en tant que modulateurs du récepteur ep2
WO2007138282A3 (fr) Nouveaux composés
WO2007068894A3 (fr) Nouveaux composes
UA96447C2 (ru) Полиморфные формы (2s)-(4e)-n-метил-5-[3-(5-изопропоксипиридин)ил]-4-пентен-2-амина для лечения расстройств центральной нервной системы
WO2005086656A3 (fr) Derives d'heteroarylaminopyrazole utilises pour traiter le diabete
WO2007052023A3 (fr) Composes
WO2010049449A3 (fr) Nouveaux sels de sunitinib
WO2006058869A8 (fr) Pteridines substituees destinees au traitement de maladies inflammatoires
WO2009109501A3 (fr) Compositions pharmaceutiques oculaires
WO2011022393A3 (fr) Inhibiteurs de protéine de transfert de la phosphatidylcholine
WO2008033935A3 (fr) Dérivés de la vinorelbine
WO2006056607A8 (fr) Pteridines substituees pour traiter des maladies inflammatoires
WO2008152094A3 (fr) Acétamides substitués en tant que modulateurs du récepteur ep2
AU2009235968A8 (en) Novel compounds derived from taurine, process of their preparation and pharmaceutical compositions containing these
WO2010038948A3 (fr) Dérivés de pyrrole 3-carboxamide contenant de l’arylpipérazine pour le traitement de troubles dépressifs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08806781

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08806781

Country of ref document: EP

Kind code of ref document: A2